JENBURKT PHARMACEUTICALS
Back to All Ratios
|
JENBURKT PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 12.83 | 10.75 | 10.94 | 10.75 | 9.86 |
What is the latest Price to Cash Earnings (PCE) ratio of JENBURKT PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 12.83 |
| Mar2024 | 10.75 |
| Mar2023 | 10.94 |
| Mar2022 | 10.75 |
| Mar2021 | 9.86 |
How is Price to Cash Earnings (PCE) of JENBURKT PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 12.83 | 19.35 | |
| Mar2024 | 10.75 | -1.74 | |
| Mar2023 | 10.94 | 1.77 | |
| Mar2022 | 10.75 | 9.03 | |
| Mar2021 | 9.86 | - | |
Other Financial Ratios of JENBURKT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹516.8 Cr | 1% | -0.9% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,428.0 Cr | 1.5% | -3% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,426.0 Cr | -2.2% | -4.5% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,603.0 Cr | 0.8% | 2.3% | 43.9% | Stock Analytics | |
| CIPLA | ₹111,604.0 Cr | 0.4% | -4% | -7.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,775.0 Cr | 0.8% | -1.8% | -3.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 1% |
-0.9% |
-6.7% |
| SENSEX | 3.7% |
2.2% |
-7.2% |
You may also like the below Video Courses